Skip to content

Opioids for chronic pain

Study:  Patterns of opioid dispensing and associated wage replacement duration in workers with accepted claims for low back pain: a retrospective cohort study

written by Psychosomatic Addict Research study by Monash University – https://journals.lww.com/pain/Abstract/2022/08000/Patterns_of_opioid_dispensing_and_associated_wage.13.aspx The write up of the study on the Monash University website: https://www.monash.edu/medicine/news/latest/2022-articles/opioid-prescription-patterns-in-injured-workers It has been a while since I’ve had the pleasure of writing up a scientific study on chronic pain. Not because I… Read More »Study:  Patterns of opioid dispensing and associated wage replacement duration in workers with accepted claims for low back pain: a retrospective cohort study

opioid pain medication

Study: Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes

Published March 2021 https://pubmed.ncbi.nlm.nih.gov/33300138/ This is a very large study with 2,021,371 participants. It looked at patients who were prescribed an opioid for pain and examined how many people continued to take them long-term (addiction) (3.17%) and how many experienced an opioid overdose (0.055%). It’s… Read More »Study: Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes

opioid pain medications

Study:  Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts

Many current assumptions about opioid analgesics are ill-founded. Illicit fentanyl and heroin, not opioid prescribing, now fuel the current opioid overdose epidemic. National discussion has often neglected the potentially devastating effects of uncontrolled chronic pain. Opioid analgesic prescribing and related overdoses are in decline, at great cost to patients with pain who have benefited or may benefit from, but cannot access, opioid analgesic therapy.

opioid pain medications

Study:  Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrolment randomized withdrawal trials

This meta-analysis of FDA-required double-blind, randomized, placebo-controlled clinical trials of opioid analgesics for the treatment of chronic pain has shown that there is an ample evidence base supporting the efficacy of opioid analgesics for at least 3 months’ duration, a standard period for the evaluation of treatments for chronic pain and other chronic disorders

UNSW Sydney

GUIDELINE FOR DEPRESCRIBING OPIOID ANALGESICS

This is important for every Australian who is on long-term opioid therapy for chronic pain https://www.opioiddeprescribingguideline.com Most people in the chronic pain community will not be aware that there are Draft Opioid Deprescribing Guidelines currently open for public comment. The Draft Guidelines and a template… Read More »GUIDELINE FOR DEPRESCRIBING OPIOID ANALGESICS

opioid pain medication

Study: “One Size Fits All” Doesn’t Fit When It Comes to Long-Term Opioid Use for People with Chronic Pain

M. E. Lynch &J. KatzPublished online: 04 May 2017 Information courtesy of Kev James, Chronic Pain Patient Advocate. LinkedIn Source: https://www.tandfonline.com/doi/full/10.1080/24740527.2017.1319733 This study pulls no punches: “The use of opioids in chronic non-cancer pain continues to be a flashpoint in medicine. The media and others… Read More »Study: “One Size Fits All” Doesn’t Fit When It Comes to Long-Term Opioid Use for People with Chronic Pain

opioid pain medication

Study: Appropriate and responsible use of opioids in chronic non-cancer pain

Harald Breivik First published: 09 January 2012 Information courtesy of Kev James, Chronic Pain Patient Advocate. LinkedIn Read the full study here In 2012 a group of distinguished pain clinicians from nine European countries got together to discuss the appropriate use of strong opioids for… Read More »Study: Appropriate and responsible use of opioids in chronic non-cancer pain